Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950123-01-509246
Filing Date
2001-12-13
Accepted
2001-12-13 00:00:00
Documents
5
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS INC. y55691e10-k405.txt 10-K405 340464
3 CERTIFICATE OF INCORPORATION, AS AMENDED y55691ex3-1.txt EX-3.1 41196
4 AMENDED AND RESTATED BY LAWS y55691ex3-2.txt EX-3.2 34608
5 SUBSIDIARY y55691ex21.txt EX-21 225
6 CONSENT OF KPMG LLP y55691ex23.txt EX-23 1205
  Complete submission text file 0000950123-01-509246.txt   419787
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405 | Act: 34 | File No.: 000-15190 | Film No.: 1813213
SIC: 2835 In Vitro & In Vivo Diagnostic Substances